Antimicrobial resistance could claim 39 million lives by 2050, yet the pipeline for new antibiotics is drying up. U.S. policy ...
CAMBRIDGE, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), (Seres or the Company), a leading live biotherapeutics company, today reported third quarter 2024 financial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback